Building future-ready leaders in the pharmaceutical industry
Leadership development fails most often not because the content is wrong, but because it is delivered as an event into an organization that runs on habits.
The event problem
The dominant model is still the workshop. Two or three days offsite, capable facilitation, high satisfaction scores, and a return to an entirely unchanged working environment. Participants leave motivated and are reabsorbed within a fortnight by the system they came from.
This is not a criticism of workshops, which are efficient at transferring understanding. It is a criticism of workshops used alone. Behaviour change requires repetition in the environment where the behaviour is actually performed, and a workshop cannot supply that by design.
The tell is in how organizations evaluate. When the primary measure is participant satisfaction, the programme is being assessed as an experience rather than as an intervention, and it will be optimized accordingly.
Design for transfer, not for satisfaction
Programmes that produce durable change tend to share a structure: a short input, a specific and mandatory field application, and a coaching review in which that application is discussed with someone who has authority over the participant work.
The learning happens in the third step. The first merely makes it possible. This is well established and widely ignored in practice, because the third step is the expensive one, it requires line managers to participate rather than simply to release people.
That structure has a real cost. It takes months rather than days, it consumes managerial time that is already scarce, and it makes visible which managers are and are not willing to develop their people. Organizations unwilling to pay that cost would often be better served spending considerably less and expecting proportionately less.
Develop for the stage the leader is actually at
A newly promoted first-line manager and a regional leader with a decade of experience have almost nothing in common developmentally, yet are routinely put through identical content.
The first is learning, for the first time, to get results through other people rather than personally. That is a genuine identity shift, and it usually involves a period of feeling less effective than before. The second is learning to lead through other leaders, to influence without direct authority, and to think in terms of systems rather than individuals.
Treating those as the same problem wastes the time of both. It also produces the familiar situation where experienced leaders disengage from development entirely, having sat through the same material three times at three different levels.
The capabilities that actually travel
Pharmaceutical commercial leadership is specific enough that generic leadership content transfers poorly. In our work, four capabilities consistently distinguish leaders who sustain performance.
- Coaching that changes behaviour. Not accompaniment, not feedback in general, but the disciplined practice of observing, selecting one thing, and returning to it.
- Business judgement under incomplete information. The ability to commit to a plan when the data is suggestive rather than conclusive, and to revise it without treating revision as failure.
- Cross-functional influence. Commercial outcomes increasingly depend on medical, market access and marketing colleagues over whom the leader has no authority.
- Ethical steadiness under pressure. The capability that matters most when the quarter is short and the shortcut is available.
The ethical dimension is not decoration
In a regulated, high-trust industry, leadership development that ignores ethical judgement is incomplete rather than merely lighter.
The pressure points are practical rather than abstract: how targets are communicated when they are unlikely to be met, what behaviour is quietly rewarded when the quarter is short, whether a manager is willing to escalate an uncomfortable finding, and how the organization responds the first time someone does.
Leaders learn what is genuinely acceptable from what they observe being tolerated, not from what appears on a slide during induction. Development that does not engage with that reality will be overruled by the culture around it, politely and without anyone deciding to overrule it.
Who should own it
Leadership development is usually owned by the learning function and funded from a central budget. That arrangement is administratively tidy, and it is one of the main reasons programmes fail to stick.
When development is owned centrally, line leaders experience it as something done to their teams rather than something they are accountable for. They release people, receive them back, and carry on. Nothing in their own objectives changes as a result, so nothing in their behaviour does either.
The organizations that get the most from leadership investment tend to share ownership explicitly. The learning function owns design and quality; the line leader owns application and outcome. The distinction is written down, and the line leader is asked in their own performance review what changed in their team as a result of the programme.
This is a small governance change with a disproportionate effect, because it converts development from an event the organization runs into a result somebody is answerable for.
What to measure
Satisfaction scores measure the experience and predict very little. More useful measures look at what leaders do differently afterwards.
- Coaching frequency, and separately, coaching quality as observed by a second-line leader
- Retention within the leader own team, compared with the same team before
- The quality of business plans, assessed against a defined standard rather than impressionistically
- Whether the leader people are being promoted, which is the clearest single indicator of a developing manager
These are slower to collect and harder to attribute. They are also the only measures that answer the question the investment was made to answer, and organizations that adopt them tend to make better decisions about which programmes to continue.